Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Agasthya Rasayanam is a classical Ayurvedic polyherbal formulation, typically prepared as a semi-solid electuary (lehyam). It is primarily indicated for the management of chronic respiratory disorders, including asthma, bronchitis, and persistent cough. The formulation is named after the sage Agastya and is highly regarded in traditional medicine for its rejuvenative (Rasayana) properties. Its primary active ingredient is Haritaki (Terminalia chebula), which is processed alongside Dashamoola (a group of ten medicinal roots) and other herbs in a base of jaggery, honey, and ghee. It functions as an immunomodulator and bronchodilator, helping to alleviate airway congestion, improve lung capacity, and enhance resistance against recurrent respiratory infections. Chaithanya Herbals manufactures this formulation as a commercially available retail Ayurvedic product.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Agasthya Rasayanam.